---
title: "礼来公司等申请者在最高法院拒绝多项上诉时被拒绝受理申请"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/286789989.md"
description: "礼来在被最高法院拒绝的制药公司中，该法院驳回了与医疗保健和商业案件相关的多项上诉。此决定降低了最高法院在这些问题上立即介入的可能性。消息公布后，礼来的股价下跌了 2.2%，至 985.25 美元"
datetime: "2026-05-18T14:29:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286789989.md)
  - [en](https://longbridge.com/en/news/286789989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286789989.md)
---

# 礼来公司等申请者在最高法院拒绝多项上诉时被拒绝受理申请

10:29 AM EDT, 05/18/2026 (MT Newswires) -- Eli Lilly ( LLY ) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders.

The Court vacated and remanded several cases, including voting rights disputes, while rejecting review in multiple pharmaceutical and healthcare-related petitions, reducing the likelihood of near-term Supreme Court intervention in those matters.

The Court granted review in one education case while denying dozens of appeals across civil, criminal, regulatory, and healthcare matters, with Justice Sotomayor separately concurring in the denial of certiorari in a sentencing case in which relief had already been granted.

Shares of Eli Lilly ( LLY ) were down 2.2% in Monday trading.

Price: 985.25, Change: -19.68, Percent Change: -1.96

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### 相关股票

- [LLY.US](https://longbridge.com/zh-CN/quote/LLY.US.md)
- [LLYX.US](https://longbridge.com/zh-CN/quote/LLYX.US.md)
- [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md)
- [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [ELIS.US](https://longbridge.com/zh-CN/quote/ELIS.US.md)
- [LLYZ.US](https://longbridge.com/zh-CN/quote/LLYZ.US.md)
- [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [ELIL.US](https://longbridge.com/zh-CN/quote/ELIL.US.md)
- [LABU.US](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [LABD.US](https://longbridge.com/zh-CN/quote/LABD.US.md)
- [IXJ.US](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md)

## 相关资讯与研究

- [礼来押注非病毒基因药物，斥资 2.02 亿美元收购 Engage Bio](https://longbridge.com/zh-CN/news/287086583.md)
- [Scholar Rock 将出席杰富瑞全球医疗保健大会，聚焦 SMA 新药 apitegromab 关键审批](https://longbridge.com/zh-CN/news/287069556.md)
- [强生重症肌无力治疗新药获国家药监局批准上市](https://longbridge.com/zh-CN/news/287196062.md)
- [国信证券：2026 年内关注口服减重药物商业化进展 MNC 在 CVRM 赛道布局更新](https://longbridge.com/zh-CN/news/287148565.md)
- [制药巨头集体拥抱 AI 智能体：百时美施贵宝向 3 万员工推广 Claude](https://longbridge.com/zh-CN/news/287074661.md)